Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2024 Jul 30;15:1469689. doi: 10.3389/fimmu.2024.1469689

Retraction: Cancer-associated fibroblasts-derived exosomes suppress immune cell function in breast cancer via the miR-92/PD-L1 pathway

Frontiers Editorial Office*
PMCID: PMC11319807  PMID: 39139568

The journal retracts the 09 October 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. Images presented in this article were subsequently also identified in publications from unrelated author groups. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

Frontiers would like to thank Dr Sholto David for contacting the journal regarding the published article, the concerns regarding which were also documented on PubPeer.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and agree to retract the article. This communication has been recorded by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES